Press release
Diphtheria Market 2024-2033 : Industry Analysis, Size, Share, Growth And Forecast
Diphtheria Global Market Report 2024
According to The Business Research Company's, The diphtheria market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $8.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.
The diphtheria market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report
Market Drivers and Trends:
The rising prevalence of bacterial infections is expected to propel the growth of the diphtheria market going forward. A bacterial infection is a sickness or condition attributed to bacterial growth or the toxins produced by bacteria that invade the body. Diphtheria is a serious infection caused by bacteria strains that suppress the immune system and promote the proliferation of Corynebacterium diphtheria. For instance, in November 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based public health organization, the number of reported infections of Acinetobacter species resistant to various antimicrobial groups was over doubled (+121%) the average in the year 2021 and more than 35,000 people die from antimicrobial-resistant infections in the EU each year. Furthermore, the number of Klebsiella pneumonia cases increased by 31% in 2020 and another 20% in the year 2021. Therefore, the rising prevalence of bacterial infections will drive the diphtheria market.
Companies operating in the diphtheria market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced that the US Food and Drug Administration (FDA) approved BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for immunization throughout the third month of the pregnancy to help prevent pertussis (whooping cough) in infants younger than two months of age. The Tdap immunization administered during pregnancy gives the highest protection against whooping cough in the early months of life for newborns. Protective antibodies are transferred from mother to kid when pregnant women are immunized.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp
Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.
Diphtheria Market 2024 Key Insights:
• The Diphtheria Market is expected to grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.
• Rising Prevalence Of Bacterial Infections Fuels Growth In The Diphtheria Market
• Companies Innovate And Gain FDA Approval For Diphtheria Prevention Drugs
• Asia-Pacific was the largest region in the diphtheria market in 2023. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13016&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diphtheria Market 2024-2033 : Industry Analysis, Size, Share, Growth And Forecast here
News-ID: 3668360 • Views: …
More Releases from The Business Research Company
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented.
Direct Coombs Test (DCT) Antibody Market Size…
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential.
Projected Market Size and Growth for Dental Practice Analytics Dashboards
The market for dental practice analytics dashboards is…
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
The datacenters market is on the verge of remarkable growth as digital transformation accelerates across multiple industries. Driven by cutting-edge technologies and changing business needs, this sector is set to expand rapidly in the coming years. Let's explore the current market size, the main companies involved, emerging trends, and the key segments shaping the future of datacenters globally.
Steady Growth Forecast for the Datacenters Market by 2029
The global datacenters market is…
Key Industry Players Strengthening Their Position In The Contract Food Service M …
The contract food service management sector is on track for notable expansion as consumer preferences and operational models evolve. Driven by rising health consciousness and technological advancements, this market is adapting to meet new demands while exploring innovative solutions. Let's delve into the current market size, key players, emerging trends, and major segments shaping the industry's future.
Projected Market Value and Growth Dynamics in the Contract Food Service Management Market
The contract…
More Releases for Diphtheria
Diphtheria Market Trends That Will Shape the Next Decade: Insights from Companie …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Diphtheria Market Size By 2025?
The overall valuation of the diphtheria market has experienced a robust expansion recently, projected to increase from $8.91 billion in 2024 to $9.39 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.4%; this forward momentum during the…
Diphtheria Market: Major Trends Reshaping the Future of the Industry
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Diphtheria Industry Market Size Be by 2025?
In the last few years, there has been robust growth in the market size of diphtheria. It is set to expand from $8.91 billion in 2024 to $9.51 billion in 2025 with a compound annual growth rate (CAGR) of…
Prominent Diphtheria Market Trend for 2025: Companies Innovate And Gain FDA Appr …
What Are the Projected Growth and Market Size Trends for the Diphtheria Market?
The diphtheria market will grow from $8.91 billion in 2024 to $9.51 billion in 2025, at a CAGR of 6.7%. This growth is driven by vaccine development, immunization campaigns, increased healthcare awareness, and improved healthcare infrastructure.
The diphtheria market is expected to grow steadily, reaching $12.35 billion by 2029 with a CAGR of 6.8%. This growth is attributed to…
Unveiling Insights: Global Diphtheria Toxoid Market Analysis 2023-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Welcome to our comprehensive analysis of the Global Diphtheria Toxoid Market, covering a broad spectrum of factors shaping its growth trajectory from 2023 to 2031. Amidst the backdrop of the COVID-19 pandemic, the market dynamics have witnessed significant shifts, influencing the demand-supply equilibrium and strategic decisions across various segments. In this blog, we delve into the market size, share, and the impact of COVID-19, alongside a detailed examination of resin…
Diphtheria Treatment Market to Witness Robust Expansion by 2029
Diphtheria Treatment market is expected to grow at a CAGR of 5.5% from 2023 to 2029. The growth in the market can be attributed to the increasing incidence of diphtheria, rising awareness about diphtheria and its prevention, and technological advancements in the field of diphtheria treatment. Important changes in the business allow key players to attain larger profits. This Diphtheria Treatment Market study report is the best way to make…
Diphtheria Vaccine Market Size, Share, Industry, Forecast to 2030
The Diphtheria Vaccine Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Diphtheria Vaccine market. This report explores all the key factors affecting the growth of the global Diphtheria Vaccine market, including…
